Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03032250
Other study ID # IRB00038084
Secondary ID NCI-2016-02045CC
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2017
Est. completion date April 10, 2020

Study information

Verified date December 2022
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies how well Prepare to Care kit works in improving caregiver support in patients with stage I-IV head and neck cancer that is new or has come back. Prepare to Care kit may increase knowledge about head and neck cancer and enhance stress-management skills.


Description:

PRIMARY OBJECTIVES: I. To assess feasibility (accrual, participation, and retention) and acceptability of a supported self-management intervention for psycho-education and stress management skills building designed for informal caregivers (intervention group n=20; waitlist control group, n=20) of head and neck cancer (HNC) patients undergoing radiotherapy (RT). II. To obtain preliminary data on caregiver intermediate (self-efficacy for [a] coping with cancer and [b] abbreviated progressive muscle relaxation) and outcome variables (burden, psychological distress, quality of life) in intervention caregivers and waitlist control caregivers at the start of radiation (T1), end of radiation (T2), and 6-weeks post-radiation (T3). III. To compare intermediate (self-efficacy for (a) coping with cancer and (b) abbreviated progressive muscle relaxation) and outcome variables (burden, psychological distress, quality of life) between intervention caregivers and waitlist control caregivers at T1, T2, and T3. IV. To obtain preliminary data on caregiver cortisol response (cortisol slope, cortisol awakening OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Caregivers watch introduction video on a digital video disc (DVD) over 10 minutes at baseline. Caregivers receive Prepare to Care kit including 8 workbook modules and complete at least 1 module over 30-45 minutes each week. Caregivers also attend interventionist session over 10-30 minutes weekly. GROUP II: Caregivers receive educational intervention as in Group I but do not attend interventionist sessions.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date April 10, 2020
Est. primary completion date April 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: CAREGIVERS: - Providing the majority of the informal (unpaid) care during radiation therapy for a patient meeting inclusion criteria and participating in study CARE-RECIPIENTS: - Has a new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV squamous cell carcinoma of the upper aerodigestive tract (including lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, and larynx cancers) - Has planned external beam radiotherapy (+/- chemotherapy) for 6-7 weeks - Has an informal (unpaid) caregiver during radiation therapy who is participating in study Exclusion Criteria: - CAREGIVERS: Has a current cancer diagnosis - CAREGIVERS: Cannot read/communicate in English - CAREGIVERS: Have an endocrine disorder (e.g., diabetes and thyroid disorders), or is currently taking a steroid based medication will not be eligible to participate in the saliva portion of the study - CARE-RECIPIENTS: Cannot read/communicate in English

Study Design


Related Conditions & MeSH terms

  • Carcinoma
  • Carcinoma, Squamous Cell
  • Caregiver
  • Head and Neck Neoplasms
  • Malignant Head and Neck Neoplasm
  • Paranasal Sinus Squamous Cell Carcinoma
  • Recurrence
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal SCC
  • Recurrent Paranasal Sinus Squamous Cell Carcinoma
  • Salivary Gland Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Head and Neck
  • Stage I Hypopharyngeal Squamous Cell Carcinoma
  • Stage I Laryngeal Squamous Cell Carcinoma
  • Stage I Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage I Oropharyngeal Squamous Cell Carcinoma
  • Stage II Hypopharyngeal Squamous Cell Carcinoma
  • Stage II Laryngeal Squamous Cell Carcinoma
  • Stage II Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage II Oropharyngeal Squamous Cell Carcinoma
  • Stage III Hypopharyngeal Squamous Cell Carcinoma
  • Stage III Laryngeal Squamous Cell Carcinoma
  • Stage III Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage III Oropharyngeal Squamous Cell Carcinoma
  • Stage IV Hypopharyngeal Squamous Cell Carcinoma
  • Stage IV Laryngeal Squamous Cell Carcinoma
  • Stage IV Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage IV Oropharyngeal Squamous Cell Carcinoma
  • Stage IVA Hypopharyngeal Squamous Cell Carcinoma
  • Stage IVA Laryngeal Squamous Cell Carcinoma
  • Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma
  • Stage IVB Hypopharyngeal Squamous Cell Carcinoma
  • Stage IVB Laryngeal Squamous Cell Carcinoma
  • Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma
  • Stage IVC Hypopharyngeal Squamous Cell Carcinoma
  • Stage IVC Laryngeal Squamous Cell Carcinoma
  • Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma
  • Stage IVC Oropharyngeal Squamous Cell Carcinoma

Intervention

Other:
Communication Intervention
Attend interventionist sessions
Watch video
Watch video on a DVD
Module completion of the Prepare to Care kit
Complete modules of the Prepare to Care kit
Quality-of-Life Assessment
Ancillary studies
Survey Administration
Ancillary studies
Salivary cortisol collection
Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.

Locations

Country Name City State
United States Comprehensive Cancer Center of Wake Forest University Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Wake Forest University Health Sciences National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Salivary Cortisol Collection For eligible caregivers only - collected three times a day (at awakening, 30 minutes post-awakening, and bedtime) for two consecutive days following T1 (start of radiation), T2 (end of radiation), and T3 (6 weeks post radiation). To obtain preliminary data on caregiver cortisol response (cortisol slope, cortisol awakening response, area under the curve, and intra-individual cortisol variability). Investigators will use a mixed model to evaluate differences between the groups in these parameters at times T1 and T2 and T3 Up to 1 year
Primary Number of Participants Noting Quite a Bit/Very Much Helpful to Survey Questions 10-item quantitative survey will be developed for study to assess how much caregivers liked different aspects of the intervention. Acceptability will be summarized quantitatively and qualitatively. These acceptability questions were asked only of caregivers in the intervention group - Group 1 Supportive Care (Prepare to Care Kit). All data is based on participants answering the acceptability questions as "Quite a Bit/Very Much Helpful" for the intervention materials. Not all participants answered this part of the outcome measure. Six weeks post radiation therapy
Primary Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of Recruitment 38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month Up to 1 year
Primary Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA) 21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Minimum and maximum scoring scale: BASELINE: Scores for esteem 15-31; lack of family support 5-15, impact of finances 3-12, impact of schedule 12-23, impact of health 11-16). AFTER RADIOTHERAPY: Scores for esteem 20-31; lack of family support 9-17, impact of finances 7-11, impact of schedule 14-22, impact of health 12-17). The higher the score the more the item being assessed impacted the participant. Baseline and following radiotherapy, assessed up to 1 year
Primary Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD) The score is the sum of the 20 questions. Possible scoring range is 0-60. A score of 16 points or more is considered depressed. Before and after radiotherapy, assessed up to 1 year
Primary Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc) 35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns). The Cqol-Canc has demonstrated validity and reliability. Minimum and maximum score at baseline is a range of 9-78 and after radiotherapy a range of 2-73. The higher the score the greater the level of change in the quality of life for participants. Before and after radiotherapy, assessed up to 1 year
Primary Frequency of Intervention Modules Utilized Assessed by Caregiver Logs Data on intervention resources used and time spent using them based on caregivers in intervention group Up to 1 year
Primary Number of Participants in Agreement to Perform Interventions Participation assessed by number of eligible participants who agreed to participate and complete study interventions. Up to 1 year
Primary Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate Up to 1 year
Primary Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR) A 3-item instrument developed for study to evaluate self-efficacy in APMR. Minimum to maximum scores range from 3-27. Higher scores demonstrate higher self efficacy in participants. At baseline and up to the end of radiotherapy, assessed up to 1 year
Primary Self-efficacy in Coping With Cancer Caregiver Inventory 21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions); demonstrated validity and reliability. Minimum and maximum scores range from 10-63. Higher scores indicate higher self-efficacy in coping with cancer from the participants. At baseline and up to the end of radiotherapy, assessed up to 1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03671226 - Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center N/A
Active, not recruiting NCT03287492 - RCT of QPS vs General Information Sheet N/A
Completed NCT06269276 - Caregiver Contribution to Self-Care in Ostomy Patient Index: Turkish Validity and Reliability Study
Completed NCT03675217 - Physical Exercise Program for Family Caregivers of Dependent Patients N/A
Not yet recruiting NCT05970471 - Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital
Completed NCT04587583 - WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers Phase 1/Phase 2
Completed NCT03689179 - Virtual Coaching to Maximize Dementia Caregivers' Respite Time Use N/A
Recruiting NCT05441384 - It's Time to Address Fear of Cancer Recurrence in Family Caregivers: Online Version of the Fear Of Recurrence Therapy N/A
Enrolling by invitation NCT05068765 - The Effect of the Psychoeducation Program on the Subjective Well-being of Caregivers N/A
Active, not recruiting NCT03267524 - Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers N/A
Active, not recruiting NCT03686007 - Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients N/A
Completed NCT02603367 - COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung Cancer N/A
Completed NCT04747210 - Contextual Coaching Versus Training Workshop for Assistants in Special Education. N/A
Completed NCT04058886 - Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers N/A
Completed NCT03775616 - Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers N/A
Completed NCT03528863 - Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers N/A
Completed NCT06132022 - The Effect of Mandala Application on Anxiety Level and Caregiver Burden in Palliative Care N/A
Withdrawn NCT04085081 - Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers N/A
Not yet recruiting NCT05245305 - The Effect of Mindfulness-Based Stress Reduction Program N/A
Completed NCT03902535 - Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers